Alpine Bank Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
AI
Alpine Bank Wealth Management's BIO Position: Q2 2026 in Review
Alpine Bank Wealth Management opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 55 shares worth $16.1K. The stake represents ﹤0.01% of the portfolio and ranks #357 among its holdings. This is a return to the name: Alpine Bank Wealth Management previously reported a position in BIO as recently as Q3 2025.
Alpine Bank Wealth Management first reported a position in BIO in Q3 2024 and has held it in 5 quarters since. The position peaked at $18.4K in Q3 2024. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- Alpine Bank Wealth Management held 55 shares of Bio-Rad Laboratories Class A worth $16.1K as of Q2 2026.
- Bio-Rad Laboratories Class A was a new Alpine Bank Wealth Management position in Q2 2026.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Alpine Bank Wealth Management's portfolio in Q2 2026, its #357 holding.
- Alpine Bank Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q3 2024 and has held it in 5 quarters since.
- Alpine Bank Wealth Management's Bio-Rad Laboratories Class A position peaked at $18.4K in Q3 2024.
- 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on Alpine Bank Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.